196 related articles for article (PubMed ID: 37408007)
1. Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma.
Wang Z; Tang XL; Zhao MJ; Zhang YD; Xiao Y; Liu YY; Qian CF; Xie YD; Liu Y; Zou YJ; Yang K; Liu HY
J Nanobiotechnology; 2023 Jul; 21(1):210. PubMed ID: 37408007
[TBL] [Abstract][Full Text] [Related]
2. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
[TBL] [Abstract][Full Text] [Related]
3. ROS-Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy.
Zheng M; Liu Y; Wang Y; Zhang D; Zou Y; Ruan W; Yin J; Tao W; Park JB; Shi B
Adv Mater; 2019 Sep; 31(37):e1903277. PubMed ID: 31348581
[TBL] [Abstract][Full Text] [Related]
4. Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy.
Jiang T; Qiao Y; Ruan W; Zhang D; Yang Q; Wang G; Chen Q; Zhu F; Yin J; Zou Y; Qian R; Zheng M; Shi B
Adv Mater; 2021 Nov; 33(45):e2104779. PubMed ID: 34751990
[TBL] [Abstract][Full Text] [Related]
5. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
[TBL] [Abstract][Full Text] [Related]
6. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
[TBL] [Abstract][Full Text] [Related]
7. Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy.
He W; Li X; Morsch M; Ismail M; Liu Y; Rehman FU; Zhang D; Wang Y; Zheng M; Chung R; Zou Y; Shi B
ACS Nano; 2022 Apr; 16(4):6293-6308. PubMed ID: 35353498
[TBL] [Abstract][Full Text] [Related]
8. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
Gutkin A; Cohen ZR; Peer D
Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
[TBL] [Abstract][Full Text] [Related]
9. Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma.
Tang X; Wang Z; Xie Y; Liu Y; Yang K; Li T; Shen H; Zhao M; Jin J; Xiao H; Liu H; Gu N
ACS Nano; 2023 Feb; 17(4):4062-4076. PubMed ID: 36759969
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.
Kievit FM; Wang K; Ozawa T; Tarudji AW; Silber JR; Holland EC; Ellenbogen RG; Zhang M
Nanomedicine; 2017 Oct; 13(7):2131-2139. PubMed ID: 28614736
[TBL] [Abstract][Full Text] [Related]
11. Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic Nanomedicine.
Zou Y; Liu Y; Yang Z; Zhang D; Lu Y; Zheng M; Xue X; Geng J; Chung R; Shi B
Adv Mater; 2018 Dec; 30(51):e1803717. PubMed ID: 30328157
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment.
Zou Y; Sun Y; Wang Y; Zhang D; Yang H; Wang X; Zheng M; Shi B
Nat Commun; 2023 Jul; 14(1):4557. PubMed ID: 37507371
[TBL] [Abstract][Full Text] [Related]
13. TfR Aptamer Enhanced Blood-Brain Barrier Penetration of Biomimetic Nanocomplexes for Intracellular Transglutaminase 2 Imaging and Silencing in Glioma.
Su J; Yao Z; Chen Z; Zhou S; Wang Z; Xia H; Liu S; Wu Y
Small; 2022 Oct; 18(40):e2203448. PubMed ID: 35980938
[TBL] [Abstract][Full Text] [Related]
14. A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in Glioblastoma.
Birch JL; Strathdee K; Gilmour L; Vallatos A; McDonald L; Kouzeli A; Vasan R; Qaisi AH; Croft DR; Crighton D; Gill K; Gray CH; Konczal J; Mezna M; McArthur D; Schüttelkopf AW; McConnell P; Sime M; Holmes WM; Bower J; McKinnon HJ; Drysdale M; Olson MF; Chalmers AJ
Cancer Res; 2018 Nov; 78(22):6509-6522. PubMed ID: 30279244
[TBL] [Abstract][Full Text] [Related]
15. Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes.
Shi Y; Jiang Y; Cao J; Yang W; Zhang J; Meng F; Zhong Z
J Control Release; 2018 Dec; 292():163-171. PubMed ID: 30408555
[TBL] [Abstract][Full Text] [Related]
16. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
[TBL] [Abstract][Full Text] [Related]
17. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
18. ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
Xu Q; Hu C; Zhu Y; Wang K; Lal B; Li L; Tang J; Wei S; Huang G; Xia S; Lv S; Laterra J; Jiang Y; Li Y
Cancer Lett; 2020 Jul; 482():126-135. PubMed ID: 31954770
[TBL] [Abstract][Full Text] [Related]
19. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.
Martins C; Araújo M; Malfanti A; Pacheco C; Smith SJ; Ucakar B; Rahman R; Aylott JW; Préat V; Sarmento B
Small; 2023 Jun; 19(22):e2300029. PubMed ID: 36852650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
